Short, simplified video guide
Audio version:
www.amazon.com/dp/B07BR3LZW7/ref=dbs_p_adbl_dam
Printed version:
Also recomended, what ever you find relevant on hubermanlab.com
hubermanlab.com/
e.g fasting, metabolism…
Short, simplified video guide
Audio version:
www.amazon.com/dp/B07BR3LZW7/ref=dbs_p_adbl_dam
Printed version:
Also recomended, what ever you find relevant on hubermanlab.com
hubermanlab.com/
e.g fasting, metabolism…
Corynoxine, isolated from Uncaria rhynchophylla, promotes the clearance of alpha-synuclein
www.ncbi.nlm.nih.gov/pubmed/24522518
Corynoxine, isolated from Uncaria rhynchophylla, promotes the clearance of alpha-synuclein via mTOR pathway [R].
use of Uncaria rhynchophylla, known as “Gou-teng” herb extract
examine.com/supplements/uncaria-rhynchophylla/
www.ncbi.nlm.nih.gov/pubmed/29940559
buy uncaria-rhynchophylla:
buy Corynoxine:
www.alibaba.com/trade/search?fsb=y&IndexArea=product_en&CatId=&SearchText=Corynoxine
Action item:
q10 1200mg/day
Creatine
type 2 diabetes is associated with an increased risk of Parkinson’s disease. Surveillance bias might account for higher rates in diabetes. The mechanism behind this association between diabetes and disease is not known
care.diabetesjournals.org/content/early/2007/01/24/dc06-2011.short
Mutations in α-synuclein cause some cases of familial PD. Several lines of transgenic mice that overexpress wild type or mutant human α-synuclein exhibit progressive accumulation of α-synuclein in neurons, motor dysfunction and death (Crabtree and Zhang, 2012). Mice expressing mutant (A53T) α-synuclein exhibit impaired autonomic regulation of heart rate characterized by elevated resting heart rate associated with accumulation of α-synuclein aggregates in the brainstem and reduced parasympa-thetic (cardiovagal) tone (Griffioen et al., 2013). Maintenance of the α-synuclein mutant mice on ADF reversed the autonomic deficit, whereas a high fat diet exacerbated the autonomic deficit (Griffioen et al., 2013). Consistent with the latter findings, a high fat diet hastened the onset of motor dysfunction and brainstem pathology in another line of α-synuclein mutant mice, which was associated with reduced activity of kinases known to be involved in neurotrophic factor signaling (Rotermund et al., 2014). In addition to enhancement of neurotrophic factor/BDNF signaling, IF may counteract PD-related pathogenic processes by stimulating autophagy. Indeed, inhibition of mTOR with rapamycin, which stimulates autophagy, reduced oxidative stress and synaptic damage, and improved motor function in a α-synuclein accumulation-based mouse model of PD (Bai et al., 2015).
supplements:
polyphenols, green tea – EGCG, lycopene, curcumine, Vitamin C
Brain:
CBD?
Heart
for MPTP or similar drag exposure
www.naturalstacks.com/blogs/news/magnesium
www.naturalnews.com/046401_magnesium_dietary_supplements_nutrient_absorption.html
magnesium deficiency can cause hreart palpatation and also calcification of heart and blood vessle
general association between magnesium and heart health www.ncbi.nlm.nih.gov/pmc/articles/PMC3957229/
magnesium salts could reduce the progress of aortic valve stenosis
www.ncbi.nlm.nih.gov/pubmed/19131578/
www.ncbi.nlm.nih.gov/pmc/articles/PMC4744893/#s002
motor learning activated by stressor – speed, to adapt to the stressor,result is speed and performance when in speed
i assume it goes both ways and e.g. Zen meditation will slow onedown, also depresion/LH/static job
possible treatment -external speed (treadmill),external speed /pulse measurement
————————–
I speculate that high intensity over continues period of time develops (up regulate) dopamine secretion. that includes brain games
Brain
AD – See Bredesen
PD –
A pilot study in PD patients testing a GLP-1 receptor agonist that is currently on the market as a treatment for type 2 diabetes (exendin-4, Byetta) also showed encouraging effects. Several other clinical trials are currently ongoing in AD patients, testing another GLP-1 analogue that is on the market (liraglutide, Victoza). Recently, a third GLP-1 receptor agonist has been brought to the market in Europe (Lixisenatide, Lyxumia), which also shows very promising neuroprotective effects. This review will summarise the range of these protective effects that those drugs have demonstrated. GLP-1 analogues show promise in providing novel treatments that may be protective or even regenerative in AD and PD, something that no current drug does.
Drugs developed for treatment of diabetes show protective effects in Alzheimer’s and Parkinson’s diseases.
www.ncbi.nlm.nih.gov/pubmed/28927992
חקייני אינקרטין (Incretin Mimetics)
Heart:
Gut
See Ronda Patrick
related treatment option for PD see https://1.getmanaged.online/nly01-halts-pd/
Similar drugs to NLY01 already approved by the Food and Drug Administration for the treatment of type 2 diabetes include exenatide, lixisenatide, liraglutide and dulaglutide, each of which can cost approximately $2,000 for a 90-day supply. NLY01 is a long-acting drug with improved the brain penetration compared to these approved drugs for diabetes.
www.sciencedaily.com/releases/2018/07/180702120505.htm
afforable:
dir.indiamart.com/impcat/liraglutide.html
oil pulling suggested by Bredesen to prevent bactermia
ginger and lavender anecdotal evidence
Dr Andrue Huberman – Nicotine can hold off certain types of PD and AD, and it also increase neuroplacticity
www.youtube.com/shorts/P1I-gHB8Ucc
more information:
Neuroprotective effect of nicotine
A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson’s disease.
Modifiable Risk Factors of Parkinson’s Disease (multiple studies)
byu/magic-theater inCholinergicHypothesis